APO Research
Talk to an analyst

APO RESEARCH · REPORT

GABA (γ-aminobutyric acid)

GABA (γ-aminobutyric acid) is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

GABA (γ-aminobutyric acid) is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.

Selected research

Market Outlook & Growth Opportunities

Global GABA (γ-aminobutyric acid) Market Outlook and Growth Opportunities 2026

22 December 2025198 pages

Choose your research edition.

Industry ResearchGABA (γ-aminobutyric acid) Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal GABA (γ-aminobutyric acid) Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal GABA (γ-aminobutyric acid) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GABA (γ-aminobutyric acid) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal GABA (γ-aminobutyric acid) Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

GABA (γ-aminobutyric acid) is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.

China is the largest GABA (γ-aminobutyric acid) market with about 71% market share. Japan is follower, accounting for about 12% market share.

The key players are Pharma Foods International, Kyowa Hakko, Sekisui Chemical, Zhejiang YiWan Biolabs, Shanghai Richen, Guangdong Luckerkong Biotech, Tianjin Shijitianlong Biotech, Ningxiang Jiayuan Biology Technology, Zhejiang Tianrui Chemical, Taizhou Xinyou Pharmaceutical & Chemical, Bloomage Freda Biopharm etc. Top 3 companies occupied about 36% market share.

Read the full market overview

This report provides an overview of the global GABA (γ-aminobutyric acid) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GABA (γ-aminobutyric acid) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GABA (γ-aminobutyric acid) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GABA (γ-aminobutyric acid) market size, projected growth trends, production technologies, key applications, and end-use industries.

GABA (γ-aminobutyric acid) Segment by Company

Pharma Foods International

Kyowa Hakko

Sekisui Chemical

Zhejiang YiWan Biolabs

Shanghai Richen

Guangdong Luckerkong Biotech

Tianjin Shijitianlong Biotech

Ningxiang Jiayuan Biology Technology

Zhejiang Tianrui Chemical

Taizhou Xinyou Pharmaceutical & Chemical

Bloomage Freda Biopharm

GABA (γ-aminobutyric acid) Segment by Production Process

Microbial Fermentation (Food Grade)

Microbial Fermentation (Feed Grade)

Chemical Synthesis

GABA (γ-aminobutyric acid) Segment by Application

Food and Pharmaceutical

Animal Feed

Plant Growth Promoter

Others

GABA (γ-aminobutyric acid) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global GABA (γ-aminobutyric acid) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions GABA (γ-aminobutyric acid) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify GABA (γ-aminobutyric acid) significant trends, drivers, influence factors in global and regions.

6. To analyze GABA (γ-aminobutyric acid) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABA (γ-aminobutyric acid) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GABA (γ-aminobutyric acid) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABA (γ-aminobutyric acid).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the GABA (γ-aminobutyric acid) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GABA (γ-aminobutyric acid) industry.

Chapter 3: Detailed analysis of GABA (γ-aminobutyric acid) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of GABA (γ-aminobutyric acid) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of GABA (γ-aminobutyric acid) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. GABA (γ-aminobutyric acid) Industry Trends Table 2. GABA (γ-aminobutyric acid) Industry Drivers Table 3. GABA (γ-aminobutyric acid) Industry Opportunities and Challenges Table 4. GABA (γ-aminobutyric acid) Industry Restraints Table 5. Global GABA (γ-aminobutyric acid) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global GABA (γ-aminobutyric acid) Revenue Share by Company (2021-2026) Table 7. Global GABA (γ-aminobutyric acid) Sales Volume by Company (MT) & (2021-2026) Table 8. Global GABA (γ-aminobutyric acid) Sales Volume Share by Company (2021-2026) Table 9. Global GABA (γ-aminobutyric acid) Average Price (USD/MT) of Company (2021-2026) Table 10. Global GABA (γ-aminobutyric acid) Company Ranking, (2024-2026) & (USD Million) Table 11. Global GABA (γ-aminobutyric acid) Key Company Manufacturing Base & Headquarters Table 12. Global GABA (γ-aminobutyric acid) Company, Product Type & Application Table 13. Global GABA (γ-aminobutyric acid) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global GABA (γ-aminobutyric acid) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Microbial Fermentation (Food Grade) Table 18. Significant Companies of Microbial Fermentation (Feed Grade) Table 19. Significant Companies of Chemical Synthesis Table 20. Global GABA (γ-aminobutyric acid) Sales Volume by Type 2021 VS 2025 VS 2032 (MT) Table 21. Global GABA (γ-aminobutyric acid) Sales Volume by Type (2021-2026) & (MT) Table 22. Global GABA (γ-aminobutyric acid) Sales Volume by Type (2027-2032) & (MT) Table 23. Global GABA (γ-aminobutyric acid) Sales Volume Share by Type (2021-2026) Table 24. Global GABA (γ-aminobutyric acid) Sales Volume Share by Type (2027-2032) Table 25. Global GABA (γ-aminobutyric acid) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global GABA (γ-aminobutyric acid) Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global GABA (γ-aminobutyric acid) Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global GABA (γ-aminobutyric acid) Sales Value Share by Type (2021-2026) Table 29. Global GABA (γ-aminobutyric acid) Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Food and Pharmaceutical Table 31. Significant Companies of Animal Feed Table 32. Significant Companies of Plant Growth Promoter Table 33. Significant Companies of Others Table 34. Global GABA (γ-aminobutyric acid) Sales Volume by Application 2021 VS 2025 VS 2032 (MT) Table 35. Global GABA (γ-aminobutyric acid) Sales Volume by Application (2021-2026) & (MT) Table 36. Global GABA (γ-aminobutyric acid) Sales Volume by Application (2027-2032) & (MT) Table 37. Global GABA (γ-aminobutyric acid) Sales Volume Share by Application (2021-2026) Table 38. Global GABA (γ-aminobutyric acid) Sales Volume Share by Application (2027-2032) Table 39. Global GABA (γ-aminobutyric acid) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global GABA (γ-aminobutyric acid) Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global GABA (γ-aminobutyric acid) Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global GABA (γ-aminobutyric acid) Sales Value Share by Application (2021-2026) Table 43. Global GABA (γ-aminobutyric acid) Sales Value Share by Application (2027-2032) Table 44. Global GABA (γ-aminobutyric acid) Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 45. Global GABA (γ-aminobutyric acid) Sales by Region (2021-2026) & (MT) Table 46. Global GABA (γ-aminobutyric acid) Sales Market Share by Region (2021-2026) Table 47. Global GABA (γ-aminobutyric acid) Sales by Region (2027-2032) & (MT) Table 48. Global GABA (γ-aminobutyric acid) Sales Market Share by Region (2027-2032) Table 49. Global GABA (γ-aminobutyric acid) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global GABA (γ-aminobutyric acid) Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global GABA (γ-aminobutyric acid) Sales Value Share by Region (2021-2026) Table 52. Global GABA (γ-aminobutyric acid) Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global GABA (γ-aminobutyric acid) Sales Value Share by Region (2027-2032) Table 54. Global GABA (γ-aminobutyric acid) Market Average Price (USD/MT) by Region (2021-2026) Table 55. Global GABA (γ-aminobutyric acid) Market Average Price (USD/MT) by Region (2027-2032) Table 56. Global GABA (γ-aminobutyric acid) Sales by Country: 2021 VS 2025 VS 2032 (MT) Table 57. Global GABA (γ-aminobutyric acid) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global GABA (γ-aminobutyric acid) Sales by Country (2021-2026) & (MT) Table 59. Global GABA (γ-aminobutyric acid) Sales Market Share by Country (2021-2026) Table 60. Global GABA (γ-aminobutyric acid) Sales by Country (2027-2032) & (MT) Table 61. Global GABA (γ-aminobutyric acid) Sales Market Share by Country (2027-2032) Table 62. Global GABA (γ-aminobutyric acid) Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global GABA (γ-aminobutyric acid) Sales Value Market Share by Country (2021-2026) Table 64. Global GABA (γ-aminobutyric acid) Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global GABA (γ-aminobutyric acid) Sales Value Market Share by Country (2027-2032) Table 66. Pharma Foods International Company Information Table 67. Pharma Foods International Business Overview Table 68. Pharma Foods International GABA (γ-aminobutyric acid) Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 69. Pharma Foods International GABA (γ-aminobutyric acid) Product Portfolio Table 70. Pharma Foods International Recent Development Table 71. Kyowa Hakko Company Information Table 72. Kyowa Hakko Business Overview Table 73. Kyowa Hakko GABA (γ-aminobutyric acid) Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 74. Kyowa Hakko GABA (γ-aminobutyric acid) Product Portfolio Table 75. Kyowa Hakko Recent Development Table 76. Sekisui Chemical Company Information Table 77. Sekisui Chemical Business Overview Table 78. Sekisui Chemical GABA (γ-aminobutyric acid) Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 79. Sekisui Chemical GABA (γ-aminobutyric acid) Product Portfolio Table 80. Sekisui Chemical Recent Development Table 81. Zhejiang YiWan Biolabs Company Information Table 82. Zhejiang YiWan Biolabs Business Overview Table 83. Zhejiang YiWan Biolabs GABA (γ-aminobutyric acid) Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 84. Zhejiang YiWan Biolabs GABA (γ-aminobutyric acid) Product Portfolio Table 85. Zhejiang YiWan Biolabs Recent Development Table 86. Shanghai Richen Company Information Table 87. Shanghai Richen Business Overview Table 88. Shanghai Richen GABA (γ-aminobutyric acid) Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 89. Shanghai Richen GABA (γ-aminobutyric acid) Product Portfolio Table 90. Shanghai Richen Recent Development Table 91. Guangdong Luckerkong Biotech Company Information Table 92. Guangdong Luckerkong Biotech Business Overview Table 93. Guangdong Luckerkong Biotech GABA (γ-aminobutyric acid) Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 94. Guangdong Luckerkong Biotech GABA (γ-aminobutyric acid) Product Portfolio Table 95. Guangdong Luckerkong Biotech Recent Development Table 96. Tianjin Shijitianlong Biotech Company Information Table 97. Tianjin Shijitianlong Biotech Business Overview Table 98. Tianjin Shijitianlong Biotech GABA (γ-aminobutyric acid) Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 99. Tianjin Shijitianlong Biotech GABA (γ-aminobutyric acid) Product Portfolio Table 100. Tianjin Shijitianlong Biotech Recent Development Table 101. Ningxiang Jiayuan Biology Technology Company Information Table 102. Ningxiang Jiayuan Biology Technology Business Overview Table 103. Ningxiang Jiayuan Biology Technology GABA (γ-aminobutyric acid) Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 104. Ningxiang Jiayuan Biology Technology GABA (γ-aminobutyric acid) Product Portfolio Table 105. Ningxiang Jiayuan Biology Technology Recent Development Table 106. Zhejiang Tianrui Chemical Company Information Table 107. Zhejiang Tianrui Chemical Business Overview Table 108. Zhejiang Tianrui Chemical GABA (γ-aminobutyric acid) Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 109. Zhejiang Tianrui Chemical GABA (γ-aminobutyric acid) Product Portfolio Table 110. Zhejiang Tianrui Chemical Recent Development Table 111. Taizhou Xinyou Pharmaceutical & Chemical Company Information Table 112. Taizhou Xinyou Pharmaceutical & Chemical Business Overview Table 113. Taizhou Xinyou Pharmaceutical & Chemical GABA (γ-aminobutyric acid) Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 114. Taizhou Xinyou Pharmaceutical & Chemical GABA (γ-aminobutyric acid) Product Portfolio Table 115. Taizhou Xinyou Pharmaceutical & Chemical Recent Development Table 116. Bloomage Freda Biopharm Company Information Table 117. Bloomage Freda Biopharm Business Overview Table 118. Bloomage Freda Biopharm GABA (γ-aminobutyric acid) Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 119. Bloomage Freda Biopharm GABA (γ-aminobutyric acid) Product Portfolio Table 120. Bloomage Freda Biopharm Recent Development Table 121. Key Raw Materials Table 122. Raw Materials Key Suppliers Table 123. GABA (γ-aminobutyric acid) Distributors List Table 124. GABA (γ-aminobutyric acid) Customers List Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. GABA (γ-aminobutyric acid) Product Image Figure 2. Global GABA (γ-aminobutyric acid) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GABA (γ-aminobutyric acid) Sales Value (2021-2032) & (US$ Million) Figure 4. Global GABA (γ-aminobutyric acid) Sales (2021-2032) & (MT) Figure 5. Global GABA (γ-aminobutyric acid) Sales Average Price (USD/MT) & (2021-2032) Figure 6. Global GABA (γ-aminobutyric acid) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Microbial Fermentation (Food Grade) Image Figure 10. Microbial Fermentation (Feed Grade) Image Figure 11. Chemical Synthesis Image Figure 12. Global GABA (γ-aminobutyric acid) Sales Volume by Type (2021 VS 2025 VS 2032) & (MT) Figure 13. Global GABA (γ-aminobutyric acid) Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global GABA (γ-aminobutyric acid) Sales Volume Share by Type (2021-2032) Figure 15. Global GABA (γ-aminobutyric acid) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global GABA (γ-aminobutyric acid) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global GABA (γ-aminobutyric acid) Sales Value Share by Type (2021-2032) Figure 18. Food and Pharmaceutical Image Figure 19. Animal Feed Image Figure 20. Plant Growth Promoter Image Figure 21. Others Image Figure 22. Global GABA (γ-aminobutyric acid) Sales Volume by Application (2021 VS 2025 VS 2032) & (MT) Figure 23. Global GABA (γ-aminobutyric acid) Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global GABA (γ-aminobutyric acid) Sales Volume Share by Application (2021-2032) Figure 25. Global GABA (γ-aminobutyric acid) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global GABA (γ-aminobutyric acid) Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global GABA (γ-aminobutyric acid) Sales Value Share by Application (2021-2032) Figure 28. Global GABA (γ-aminobutyric acid) Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 29. Global GABA (γ-aminobutyric acid) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global GABA (γ-aminobutyric acid) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global GABA (γ-aminobutyric acid) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America GABA (γ-aminobutyric acid) Sales Value (2021-2032) & (US$ Million) Figure 33. North America GABA (γ-aminobutyric acid) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe GABA (γ-aminobutyric acid) Sales Value (2021-2032) & (US$ Million) Figure 35. Europe GABA (γ-aminobutyric acid) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific GABA (γ-aminobutyric acid) Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific GABA (γ-aminobutyric acid) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America GABA (γ-aminobutyric acid) Sales Value (2021-2032) & (US$ Million) Figure 39. South America GABA (γ-aminobutyric acid) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa GABA (γ-aminobutyric acid) Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa GABA (γ-aminobutyric acid) Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. GABA (γ-aminobutyric acid) Value Chain Figure 127. Manufacturing Cost Structure Figure 128. GABA (γ-aminobutyric acid) Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Microbial Fermentation (Food Grade)
  • Microbial Fermentation (Feed Grade)
  • Chemical Synthesis
Applications
  • Food and Pharmaceutical
  • Animal Feed
  • Plant Growth Promoter
  • Others
Companies covered
  • Pharma Foods International
  • Kyowa Hakko
  • Sekisui Chemical
  • Zhejiang YiWan Biolabs
  • Shanghai Richen
  • Guangdong Luckerkong Biotech
  • Tianjin Shijitianlong Biotech
  • Ningxiang Jiayuan Biology Technology
  • Zhejiang Tianrui Chemical
  • Taizhou Xinyou Pharmaceutical & Chemical
  • Bloomage Freda Biopharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global GABA (γ-aminobutyric acid) Sales Value (2021-2032)
  4. 1.2.2 Global GABA (γ-aminobutyric acid) Sales Volume (2021-2032)
  5. 1.2.3 Global GABA (γ-aminobutyric acid) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 GABA (γ-aminobutyric acid) Market Dynamics
  1. 2.1 GABA (γ-aminobutyric acid) Industry Trends
  2. 2.2 GABA (γ-aminobutyric acid) Industry Drivers
  3. 2.3 GABA (γ-aminobutyric acid) Industry Opportunities and Challenges
  4. 2.4 GABA (γ-aminobutyric acid) Industry Restraints
3 GABA (γ-aminobutyric acid) Market by Company
  1. 3.1 Global GABA (γ-aminobutyric acid) Company Revenue Ranking in 2025
  2. 3.2 Global GABA (γ-aminobutyric acid) Revenue by Company (2021-2026)
  3. 3.3 Global GABA (γ-aminobutyric acid) Sales Volume by Company (2021-2026)
  4. 3.4 Global GABA (γ-aminobutyric acid) Average Price by Company (2021-2026)
  5. 3.5 Global GABA (γ-aminobutyric acid) Company Ranking (2024-2026)
  6. 3.6 Global GABA (γ-aminobutyric acid) Company Manufacturing Base and Headquarters
  7. 3.7 Global GABA (γ-aminobutyric acid) Company Product Type and Application
  8. 3.8 Global GABA (γ-aminobutyric acid) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global GABA (γ-aminobutyric acid) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 GABA (γ-aminobutyric acid) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 GABA (γ-aminobutyric acid) Market by Type
  1. 4.1 GABA (γ-aminobutyric acid) Type Introduction
  2. 4.1.1 Microbial Fermentation (Food Grade)
  3. 4.1.2 Microbial Fermentation (Feed Grade)
  4. 4.1.3 Chemical Synthesis
  5. 4.2 Global GABA (γ-aminobutyric acid) Sales Volume by Type
  6. 4.2.1 Global GABA (γ-aminobutyric acid) Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global GABA (γ-aminobutyric acid) Sales Volume by Type (2021-2032)
  8. 4.2.3 Global GABA (γ-aminobutyric acid) Sales Volume Share by Type (2021-2032)
  9. 4.3 Global GABA (γ-aminobutyric acid) Sales Value by Type
  10. 4.3.1 Global GABA (γ-aminobutyric acid) Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global GABA (γ-aminobutyric acid) Sales Value by Type (2021-2032)
  12. 4.3.3 Global GABA (γ-aminobutyric acid) Sales Value Share by Type (2021-2032)
5 GABA (γ-aminobutyric acid) Market by Application
  1. 5.1 GABA (γ-aminobutyric acid) Application Introduction
  2. 5.1.1 Food and Pharmaceutical
  3. 5.1.2 Animal Feed
  4. 5.1.3 Plant Growth Promoter
  5. 5.1.4 Others
  6. 5.2 Global GABA (γ-aminobutyric acid) Sales Volume by Application
  7. 5.2.1 Global GABA (γ-aminobutyric acid) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global GABA (γ-aminobutyric acid) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global GABA (γ-aminobutyric acid) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global GABA (γ-aminobutyric acid) Sales Value by Application
  11. 5.3.1 Global GABA (γ-aminobutyric acid) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global GABA (γ-aminobutyric acid) Sales Value by Application (2021-2032)
  13. 5.3.3 Global GABA (γ-aminobutyric acid) Sales Value Share by Application (2021-2032)
6 GABA (γ-aminobutyric acid) Regional Sales and Value Analysis
  1. 6.1 Global GABA (γ-aminobutyric acid) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global GABA (γ-aminobutyric acid) Sales by Region (2021-2032)
  3. 6.2.1 Global GABA (γ-aminobutyric acid) Sales by Region: 2021-2026
  4. 6.2.2 Global GABA (γ-aminobutyric acid) Sales by Region (2027-2032)
  5. 6.3 Global GABA (γ-aminobutyric acid) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global GABA (γ-aminobutyric acid) Sales Value by Region (2021-2032)
  7. 6.4.1 Global GABA (γ-aminobutyric acid) Sales Value by Region: 2021-2026
  8. 6.4.2 Global GABA (γ-aminobutyric acid) Sales Value by Region (2027-2032)
  9. 6.5 Global GABA (γ-aminobutyric acid) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America GABA (γ-aminobutyric acid) Sales Value (2021-2032)
  12. 6.6.2 North America GABA (γ-aminobutyric acid) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe GABA (γ-aminobutyric acid) Sales Value (2021-2032)
  15. 6.7.2 Europe GABA (γ-aminobutyric acid) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific GABA (γ-aminobutyric acid) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific GABA (γ-aminobutyric acid) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America GABA (γ-aminobutyric acid) Sales Value (2021-2032)
  21. 6.9.2 South America GABA (γ-aminobutyric acid) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa GABA (γ-aminobutyric acid) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa GABA (γ-aminobutyric acid) Sales Value Share by Country, 2025 VS 2032
7 GABA (γ-aminobutyric acid) Country-level Sales and Value Analysis
  1. 7.1 Global GABA (γ-aminobutyric acid) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global GABA (γ-aminobutyric acid) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global GABA (γ-aminobutyric acid) Sales by Country (2021-2032)
  4. 7.3.1 Global GABA (γ-aminobutyric acid) Sales by Country (2021-2026)
  5. 7.3.2 Global GABA (γ-aminobutyric acid) Sales by Country (2027-2032)
  6. 7.4 Global GABA (γ-aminobutyric acid) Sales Value by Country (2021-2032)
  7. 7.4.1 Global GABA (γ-aminobutyric acid) Sales Value by Country (2021-2026)
  8. 7.4.2 Global GABA (γ-aminobutyric acid) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt GABA (γ-aminobutyric acid) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt GABA (γ-aminobutyric acid) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt GABA (γ-aminobutyric acid) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pharma Foods International
  2. 8.1.1 Pharma Foods International Company Information
  3. 8.1.2 Pharma Foods International Business Overview
  4. 8.1.3 Pharma Foods International GABA (γ-aminobutyric acid) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Pharma Foods International GABA (γ-aminobutyric acid) Product Portfolio
  6. 8.1.5 Pharma Foods International Recent Developments
  7. 8.2 Kyowa Hakko
  8. 8.2.1 Kyowa Hakko Company Information
  9. 8.2.2 Kyowa Hakko Business Overview
  10. 8.2.3 Kyowa Hakko GABA (γ-aminobutyric acid) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Kyowa Hakko GABA (γ-aminobutyric acid) Product Portfolio
  12. 8.2.5 Kyowa Hakko Recent Developments
  13. 8.3 Sekisui Chemical
  14. 8.3.1 Sekisui Chemical Company Information
  15. 8.3.2 Sekisui Chemical Business Overview
  16. 8.3.3 Sekisui Chemical GABA (γ-aminobutyric acid) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sekisui Chemical GABA (γ-aminobutyric acid) Product Portfolio
  18. 8.3.5 Sekisui Chemical Recent Developments
  19. 8.4 Zhejiang YiWan Biolabs
  20. 8.4.1 Zhejiang YiWan Biolabs Company Information
  21. 8.4.2 Zhejiang YiWan Biolabs Business Overview
  22. 8.4.3 Zhejiang YiWan Biolabs GABA (γ-aminobutyric acid) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Zhejiang YiWan Biolabs GABA (γ-aminobutyric acid) Product Portfolio
  24. 8.4.5 Zhejiang YiWan Biolabs Recent Developments
  25. 8.5 Shanghai Richen
  26. 8.5.1 Shanghai Richen Company Information
  27. 8.5.2 Shanghai Richen Business Overview
  28. 8.5.3 Shanghai Richen GABA (γ-aminobutyric acid) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai Richen GABA (γ-aminobutyric acid) Product Portfolio
  30. 8.5.5 Shanghai Richen Recent Developments
  31. 8.6 Guangdong Luckerkong Biotech
  32. 8.6.1 Guangdong Luckerkong Biotech Company Information
  33. 8.6.2 Guangdong Luckerkong Biotech Business Overview
  34. 8.6.3 Guangdong Luckerkong Biotech GABA (γ-aminobutyric acid) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Guangdong Luckerkong Biotech GABA (γ-aminobutyric acid) Product Portfolio
  36. 8.6.5 Guangdong Luckerkong Biotech Recent Developments
  37. 8.7 Tianjin Shijitianlong Biotech
  38. 8.7.1 Tianjin Shijitianlong Biotech Company Information
  39. 8.7.2 Tianjin Shijitianlong Biotech Business Overview
  40. 8.7.3 Tianjin Shijitianlong Biotech GABA (γ-aminobutyric acid) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Tianjin Shijitianlong Biotech GABA (γ-aminobutyric acid) Product Portfolio
  42. 8.7.5 Tianjin Shijitianlong Biotech Recent Developments
  43. 8.8 Ningxiang Jiayuan Biology Technology
  44. 8.8.1 Ningxiang Jiayuan Biology Technology Company Information
  45. 8.8.2 Ningxiang Jiayuan Biology Technology Business Overview
  46. 8.8.3 Ningxiang Jiayuan Biology Technology GABA (γ-aminobutyric acid) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ningxiang Jiayuan Biology Technology GABA (γ-aminobutyric acid) Product Portfolio
  48. 8.8.5 Ningxiang Jiayuan Biology Technology Recent Developments
  49. 8.9 Zhejiang Tianrui Chemical
  50. 8.9.1 Zhejiang Tianrui Chemical Company Information
  51. 8.9.2 Zhejiang Tianrui Chemical Business Overview
  52. 8.9.3 Zhejiang Tianrui Chemical GABA (γ-aminobutyric acid) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Zhejiang Tianrui Chemical GABA (γ-aminobutyric acid) Product Portfolio
  54. 8.9.5 Zhejiang Tianrui Chemical Recent Developments
  55. 8.10 Taizhou Xinyou Pharmaceutical & Chemical
  56. 8.10.1 Taizhou Xinyou Pharmaceutical & Chemical Company Information
  57. 8.10.2 Taizhou Xinyou Pharmaceutical & Chemical Business Overview
  58. 8.10.3 Taizhou Xinyou Pharmaceutical & Chemical GABA (γ-aminobutyric acid) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Taizhou Xinyou Pharmaceutical & Chemical GABA (γ-aminobutyric acid) Product Portfolio
  60. 8.10.5 Taizhou Xinyou Pharmaceutical & Chemical Recent Developments
  61. 8.11 Bloomage Freda Biopharm
  62. 8.11.1 Bloomage Freda Biopharm Company Information
  63. 8.11.2 Bloomage Freda Biopharm Business Overview
  64. 8.11.3 Bloomage Freda Biopharm GABA (γ-aminobutyric acid) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Bloomage Freda Biopharm GABA (γ-aminobutyric acid) Product Portfolio
  66. 8.11.5 Bloomage Freda Biopharm Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 GABA (γ-aminobutyric acid) Value Chain Analysis
  2. 9.1.1 GABA (γ-aminobutyric acid) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 GABA (γ-aminobutyric acid) Sales Mode & Process
  6. 9.2 GABA (γ-aminobutyric acid) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 GABA (γ-aminobutyric acid) Distributors
  9. 9.2.3 GABA (γ-aminobutyric acid) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst